Bonraybio Co., Ltd. (TPE:6955)
Taiwan · Delayed Price · Currency is TWD 117.00
-1.00 (-0.85%)
At close: Jul 9, 2026
Bonraybio Market Cap
Bonraybio has a market cap or net worth of 2.9 billion as of July 9, 2026. Its market cap has decreased by -5.91% in one year.
Market Cap
2.90B
Enterprise Value
2.34B
Revenue
319.67M
Ranking
n/a
PE Ratio
28.47
Stock Price
117.00
Market Cap Chart
Since July 25, 2023, Bonraybio's market cap has increased from 1.48B to 2.90B, an increase of 96.56%. That is a compound annual growth rate of 25.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 2.90B | -20.95% |
| Dec 31, 2025 | 3.67B | 24.12% |
| Dec 31, 2024 | 2.96B | 101.25% |
| Dec 29, 2023 | 1.47B | -0.46% |
| Jul 25, 2023 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hi-Clearance | 5.79B |
| Delta Asia International | 5.72B |
| WeLeader Biomedical | 3.22B |
| A Plus Biotechnology | 2.53B |
| Wellell | 2.38B |
| Applied BioCode | 2.36B |
| Medimaging Integrated Solution | 2.33B |
| OK Biotech | 2.19B |